A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis.
Lin C, Patel AA, Huo D, Karrison T, van Besien K, Godwin J, Sher D, Weiner H, Green M, Wade JL 3rd, Klisovic R, Baer MR, Larson RA, Stock W, Odenike O.
Lin C, et al. Among authors: karrison t.
Blood Adv. 2024 Nov 26;8(22):5735-5743. doi: 10.1182/bloodadvances.2024013215.
Blood Adv. 2024.
PMID: 39250708
Free PMC article.
Clinical Trial.